Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
Bogdan Mitran, Sara S. Rinne, Mark W. Konijnenberg, Theodosia Maina, Berthold A. Nock, Mohamed Altai, Anzhelika Vorobyeva, Mats Larhed, Vladimir Tolmachev, Marion de Jong, Ulrika Rosenström, Anna Orlova
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup>Lu-DOTAGA-PEG<sub>2</sub>-RM26'. Together they form a unique fingerprint.